Importance of consultations using mobile teams in the screening and treatment of neglected tropical skin diseases in Benin.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
05 2023
Historique:
received: 06 12 2022
accepted: 15 04 2023
revised: 24 05 2023
medline: 26 5 2023
pubmed: 12 5 2023
entrez: 12 5 2023
Statut: epublish

Résumé

Since 2013, the World Health Organization has recommended integrated control strategies for neglected tropical diseases (NTDs) with skin manifestations. We evaluated the implementation of an integrated approach to the early detection and rapid treatment of skin NTDs based on mobile clinics in the Ouémé and Plateau areas of Benin. This descriptive cross-sectional study was performed in Ouémé and Plateau in Benin from 2018 to 2020. Consultations using mobile teams were performed at various sites selected by reasoned choice based on the epidemiological data of the National Program for the Control of Leprosy and Buruli Ulcer. All individuals presenting with a dermatological lesion who voluntarily approached the multidisciplinary management team on the day of consultation were included. The information collected was kept strictly anonymous and was entered into an Excel 2013 spreadsheet and analyzed with Stata 11 software. In total, 5,267 patients with various skin conditions consulted the medical team. The median age of these patients was 14 years (IQR: 7-34 years). We saw 646 (12.3%) patients presenting NTDs with skin manifestations, principally scabies, in 88.4% (571/646), followed by 37 cases of Buruli ulcer (5.8%), 22 cases of leprosy (3.4%), 15 cases of lymphatic filariasis (2.3%) and one case of mycetoma (0.2%). We detected no cases of yaws. This sustainable approach could help to decrease the burden of skin NTDs in resource-limited countries.

Identifiants

pubmed: 37172044
doi: 10.1371/journal.pntd.0011314
pii: PNTD-D-22-01534
pmc: PMC10208463
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0011314

Informations de copyright

Copyright: © 2023 Gnimavo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

Curr Trop Med Rep. 2018;5(4):247-256
pubmed: 30460172
PLoS Med. 2005 Apr;2(4):e108
pubmed: 15839744
Lancet Infect Dis. 2015 Aug;15(8):960-7
pubmed: 26088526
Lancet. 2022 Jan 29;399(10323):411
pubmed: 35093213
Cell. 2014 Jun 19;157(7):1565-76
pubmed: 24949969
J Infect Dev Ctries. 2020 Jun 29;14(6.1):16S-21S
pubmed: 32614791
Demography. 2001 Feb;38(1):115-32
pubmed: 11227840
Trans R Soc Trop Med Hyg. 2020 Dec 16;114(12):1013-1020
pubmed: 33324991
PLoS Negl Trop Dis. 2009 Aug 25;3(8):e412
pubmed: 19707588
Lancet Glob Health. 2015 Jun;3(6):e324-31
pubmed: 26001576
PLoS Negl Trop Dis. 2017 Jan 19;11(1):e0005136
pubmed: 28103250
Clin Microbiol Infect. 2012 Apr;18(4):313-23
pubmed: 22429456
Br J Dermatol. 2020 Nov;183(5):808-820
pubmed: 32034956
BMC Public Health. 2020 Apr 17;20(1):517
pubmed: 32303204
Infect Dis Poverty. 2020 Jan 28;9(1):10
pubmed: 31987053
Lancet Planet Health. 2019 Aug;3(8):e349-e356
pubmed: 31439316
J Clin Microbiol. 2014 Dec;52(12):4398-400
pubmed: 25320228
PLoS Negl Trop Dis. 2015 Sep 10;9(9):e0004005
pubmed: 26355838
Trop Med Infect Dis. 2018 Dec 25;4(1):
pubmed: 30585179
PLoS Negl Trop Dis. 2022 Nov 4;16(11):e0010908
pubmed: 36331971
Pain Rep. 2019 Dec 06;4(6):e743
pubmed: 31984287
Parasitol Res. 2017 Feb;116(2):465-475
pubmed: 27933392
BMC Infect Dis. 2019 Mar 12;19(1):247
pubmed: 30871489
PLoS Negl Trop Dis. 2018 Jun 25;12(6):e0006584
pubmed: 29939988
Curr Opin Infect Dis. 2013 Apr;26(2):127-32
pubmed: 23343887
Dermatol Clin. 2021 Jan;39(1):147-152
pubmed: 33228857
Malays Fam Physician. 2021 Sep 08;16(3):104-107
pubmed: 34938399
BMC Public Health. 2020 Aug 18;20(1):1254
pubmed: 32811449

Auteurs

Ronald Sètondji Gnimavo (RS)

Centre de Dépistage et de Traitement de la Lèpre et de l´Ulcère de Buruli de Pobè, Fondation Raoul Follereau, Pobè, Bénin.
Institut Régional de Santé Publique- Comlan Alfred Quenum, Université d'Abomey Calavi, Ouidah, Bénin.

Faraj Fajloun (F)

University of Angers, Nantes Université, CHU Angers, Inserm, INCIT, Angers, France.
Ecole Doctorale en Sciences et Technologie, Université Libanaise, Campus Rafic Hariri, Hadath, Liban.
Laboratoire d'Innovation Thérapeutique, Faculté de Sciences 2, Campus Pierre Gemayel, Fanar, Liban.

Charbel Al-Bayssari (C)

Departement of Medical Laboratory Sciences, Faculty of Health Sciences, University of Balamand, Tripoli, Lebanon.

Espoir Sodjinou (E)

Centre de Dépistage et de Traitement de la Lèpre et de l´Ulcère de Buruli de Pobè, Fondation Raoul Follereau, Pobè, Bénin.

Akimath Habib (A)

Centre de Dépistage et de Traitement de la Lèpre et de l´Ulcère de Buruli de Pobè, Fondation Raoul Follereau, Pobè, Bénin.

Line Ganlonon (L)

Centre de Dépistage et de Traitement de la Lèpre et de l´Ulcère de Buruli de Pobè, Fondation Raoul Follereau, Pobè, Bénin.

Eric Claco (E)

Centre de Dépistage et de Traitement de la Lèpre et de l´Ulcère de Buruli de Pobè, Fondation Raoul Follereau, Pobè, Bénin.

Irvine Agoundoté (I)

Centre de Dépistage et de Traitement de la Lèpre et de l´Ulcère de Buruli de Pobè, Fondation Raoul Follereau, Pobè, Bénin.

Odile Adjouavi Houngbo (OA)

Centre de Dépistage et de Traitement de la Lèpre et de l´Ulcère de Buruli de Pobè, Fondation Raoul Follereau, Pobè, Bénin.

Esaï Gimatal Anagonou (EG)

Programme National de Lutte contre la Lèpre et l'Ulcère de Buruli, Ministère de la Santé, Cotonou, Bénin.

Chabi Alphonse Olaniran Biaou (CAO)

Programme National de Lutte contre la Lèpre et l'Ulcère de Buruli, Ministère de la Santé, Cotonou, Bénin.

Adjimon Gilbert Ayélo (AG)

Programme National de Lutte contre la Lèpre et l'Ulcère de Buruli, Ministère de la Santé, Cotonou, Bénin.

Jean Gabin Houezo (JG)

Programme National de Lutte contre la Lèpre et l'Ulcère de Buruli, Ministère de la Santé, Cotonou, Bénin.

Alexandra Boccarossa (A)

University of Angers, Nantes Université, CHU Angers, Inserm, INCIT, Angers, France.

Elie Hajj Moussa (EH)

Laboratoire d'Innovation Thérapeutique, Faculté de Sciences 2, Campus Pierre Gemayel, Fanar, Liban.

Béatriz Gomez (B)

Fondation Anesvad, Henao, Bilbao, Spain.

Anna Gine (A)

Fondation Anesvad, Henao, Bilbao, Spain.

Ghislain Emmanuel Sopoh (GE)

Institut Régional de Santé Publique- Comlan Alfred Quenum, Université d'Abomey Calavi, Ouidah, Bénin.

Estelle Marion (E)

University of Angers, Nantes Université, CHU Angers, Inserm, INCIT, Angers, France.

Roch Christian Johnson (RC)

Fondation Raoul Follereau, Health Department, Paris, France.

Marie Kempf (M)

University of Angers, Nantes Université, CHU Angers, Inserm, INCIT, Angers, France.
Département de Biologie des Agents Infectieux, UF de Bactériologie, Centre Hospitalier Universitaire Angers, Angers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH